CW
ABBV icon

Curio Wealth’s AbbVie ABBV Stock Holding History

Curio Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-218
Closed -$47.4K – 83
2026
Q1 		$47.4K Buy
218
+3
+1% +$665 0.02% 134
2025
Q4 		$49.4K Sell
215
-92
-30% -$21K 0.02% 137
2025
Q3 		$71.1K Sell
307
-10
-3% -$2.04K 0.03% 109
2025
Q2 		$58.8K Buy
317
+314
+10,467% +$58.4K 0.03% 123
2025
Q1 		$60.8K Sell
3
-329
-99% -$64K 0.03% 118
2024
Q4 		$59K Buy
+332
New +$61K 0.03% 115

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Curio Wealth's ABBV Position: Q2 2026 in Review

Curio Wealth sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 218 shares — an estimated $47.4K sold.

Curio Wealth first reported a position in ABBV in Q4 2024 and held it in 6 quarters. The position peaked at $71.1K in Q3 2025. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Curio Wealth reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Curio Wealth sold 218 AbbVie shares in Q2 2026, an estimated $47.4K.
  • Curio Wealth first reported a position in AbbVie in Q4 2024 and held it in 6 quarters.
  • Curio Wealth's AbbVie position peaked at $71.1K in Q3 2025.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Curio Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.